Utility of positron emission tomography/CT in the evaluation of small bowel pathology

Carmel Geraldine Cronin, J. Scott, A. Kambadakone, O. A. Catalano, D. Sahani, M. A. Blake, S. McDermott

Research output: Contribution to journalArticle

Abstract

We describe the management principles and different roles of positron emission tomography (PET)/CT in the evaluation of patients with small bowel tumours (adenocarcinoma, gastrointestinal stromal tumour, lymphoma, metastases) from initial staging, monitoring response to treatment, to detection of recurrent disease. We also discuss the various non-malignant aetiologies of small bowel fludeoxyglucose (FDG) PET uptake, and other pitfalls in FDG PET/CT interpretation. Awareness of the imaging appearances of small bowel tumours, patterns of disease spread and potential PET/CT interpretation pitfalls are of paramount importance to optimise diagnostic accuracy.

Original languageEnglish
Pages (from-to)1211-1221
Number of pages11
JournalBritish Journal of Radiology
Volume85
Issue number1017
DOIs
Publication statusPublished - Sep 2012

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Utility of positron emission tomography/CT in the evaluation of small bowel pathology'. Together they form a unique fingerprint.

  • Cite this

    Cronin, C. G., Scott, J., Kambadakone, A., Catalano, O. A., Sahani, D., Blake, M. A., & McDermott, S. (2012). Utility of positron emission tomography/CT in the evaluation of small bowel pathology. British Journal of Radiology, 85(1017), 1211-1221. https://doi.org/10.1259/bjr/64534573